References
1. Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR,
et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med.
2008;358(19):1991-2002.
2. Bao W, Yeung E, Tobias DK, Hu FB, Vaag AA, Chavarro JE, et al.
Long-term risk of type 2 diabetes mellitus in relation to BMI and weight
change among women with a history of gestational diabetes mellitus: a
prospective cohort study. Diabetologia. 2015;58(6):1212-9.
3. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS.
Effect of treatment of gestational diabetes mellitus on pregnancy
outcomes. N Engl J Med. 2005;352(24):2477-86.
4. Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, et al.
A multicenter, randomized trial of treatment for mild gestational
diabetes. N Engl J Med. 2009;361(14):1339-48.
5. Farrar D, Simmonds M, Griffin S, Duarte A, Lawlor DA, Sculpher M, et
al. The identification and treatment of women with hyperglycaemia in
pregnancy: an analysis of individual participant data, systematic
reviews, meta-analyses and an economic evaluation. Health Technol
Assess. 2016;20(86):1-348.
6. Sacks DA, Hadden DR, Maresh M, Deerochanawong C, Dyer AR, Metzger BE,
et al. Frequency of gestational diabetes mellitus at collaborating
centers based on IADPSG consensus panel-recommended criteria: the
Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Diabetes Care.
2012;35(3):526-8.
7. Ben-Haroush A, Yogev Y, Hod M. Epidemiology of gestational diabetes
mellitus and its association with Type 2 diabetes. Diabet Med.
2004;21(2):103-13.
8. Diabetes in Pregnancy: Management from Preconception to the Postnatal
Period NICE Guideline 3. Methods, Evidence and Recommendations 2015.
9. Rebel A, Rice MA, Fahy BG. Accuracy of point-of-care glucose
measurements. J Diabetes Sci Technol. 2012;6(2):396-411.
10. McGrath RT, Donnelly VC, Glastras SJ, Preda VA, Sheriff N, Ward P,
et al. Evaluation of Blood Glucose Meter Efficacy in an Antenatal
Diabetes Clinic. Diabetes Technol Ther. 2016;18(2):68-74.
11. Kumar V, Indukuri D, Bhat N. Analysis of five glucometers available
in India. International Journal of Diabetes in Developing Countries.
2015;35(3):189-96.
12. DuBois JA, Slingerland RJ, Fokkert M, Roman A, Tran NK, Clarke W, et
al. Bedside Glucose Monitoring-Is it Safe? A New, Regulatory-Compliant
Risk Assessment Evaluation Protocol in Critically Ill Patient Care
Settings. Crit Care Med. 2017;45(4):567-74.
13. Vučić Lovrenčić M, Radišić Biljak V, Božičević S, Pape-Medvidović E,
Ljubić S. Validation of Point-of-Care Glucose Testing for Diagnosis of
Type 2 Diabetes. Int J Endocrinol. 2013;2013:206309.
14. Corporation NB. The StatStrip®
Glucose and ß-Ketone Hospital Meter Instructions for Use Manual. 2020.
15. T S. Capillary Blood Glucose Screening (Accu-Chek Advantage) for
Gestational Diabetes. J Med Assoc Thai. 2009.
16. Stavrianos C, Anastasiou E. Oral Glucose Tolerance Test Evaluation
With Forearm and Fingertip Glucose Measurements in Pregnant Women.
Diabetes Care. 2004;27(2):627-8.
17. Boriboonhirunsarn D, Robkhonburi A, Asad-dehghan M. Accuracy of
capillary blood glucose for 50-g glucose challenge test for gestational
diabetes screening. Diabetology International. 2022;13(3):561-5.
18. Bruns DE, Knowler WC. Stabilization of glucose in blood samples: why
it matters. Clin Chem. 2009;55(5):850-2.
19. Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, Kirkman MS, et
al. Guidelines and recommendations for laboratory analysis in the
diagnosis and management of diabetes mellitus. Clin Chem.
2011;57(6):e1-e47.
20. Daly N, Carroll C, Flynn I, Harley R, Maguire P, Turner M.
Evaluation of point-of-care maternal glucose measurements for the
diagnosis of gestational diabetes mellitus. BJOG: An International
Journal of Obstetrics & Gynaecology. 2017;124(11):1746-52.
21. van den Berg S, Thelen M, Boonen K. Inventarisation of the (pre)
analytical aspects of the glucose determination in Dutch laboratories:
time for harmonization. Ned Tijdschr Klin Chem Labgeneesk.
2015;40(1):69.
22. Lippi G, Montagnana M, Giavarina D. National survey on the
pre-analytical variability in a representative cohort of Italian
laboratories. Clin Chem Lab Med. 2006;44(12):1491-4.
23. Bhavadharini B, Mahalakshmi MM, Maheswari K, Kalaiyarasi G, Anjana
RM, Deepa M, et al. Use of capillary blood glucose for screening for
gestational diabetes mellitus in resource-constrained settings. Acta
Diabetol. 2016;53(1):91-7.
24. García-Claver A, Ramos-Corral R, Laviña-Fañanás C, Solans-Blecua I,
Puzo-Foncillas J. Capillary glucose concentration during oral glucose
tolerance test for the diagnosis of gestational diabetes. International
Journal of Gynecology & Obstetrics. 2020;150(2):234-40.
25. Balaji V, Madhuri BS, Paneerselvam A, Arthi T, Seshiah V. Comparison
of venous plasma glucose and capillary whole blood glucose in the
diagnosis of gestational diabetes mellitus: a community-based study.
Diabetes Technol Ther. 2012;14(2):131-4.
26. Balaji V, Balaji MS, Paneerselvam A, Thiyagarajah A, Seshiah V.
Point of care for gestational diabetes mellitus–a community-based
study. J Indian Med Assoc. 2012;110(5):314-6.
27. Hossain N, Shah T, Rajar S, Sehtoo A, Riaz M, Fawwad A, et al.
Comparison of venous plasma glucose and capillary whole blood glucose in
diagnosis of gestational diabetes: Study from Karachi, Pakistan.
Clinical Epidemiology and Global Health. 2017;5(4):185-9.
28. Afzal NI, I. Mahmood, A. Nabila, S. Fehmida. Accuracy of Fasting
Capillary Blood Glucose by Glucometer for Screening of Gestational
Diabetes Mellitus: Simplicity is the Key. JOURNAL OF THE SOCIETY OF
OBSTETRICIANS AND GYNAECOLOGISTS OF PAKISTAN. 2021;11(Online:
2307-7115):82-6.
29. Jadhav DS, and Uma N. Wankhede. Comparative study of capillary blood
glucose estimation by glucometer and venous plasma glucose estimation in
women undergoing the one step DIPSI test (diabetes in pregnancy study
group India) for screening and diagnosis of gestational diabetes
mellitus. International Journal of Reproduction, Contraception,
Obstetrics and Gynecology. 2017;6(4):1488+.
30. O’Malley EG, Reynolds CME, O’Kelly R, Killalea A, Sheehan SR, Turner
MJ. A Prospective Evaluation of Point-of-Care Measurements of Maternal
Glucose for the Diagnosis of Gestational Diabetes Mellitus. Clin Chem.
2020;66(2):316-23.
31. Adam S, Rheeder P. Evaluating the utility of a point-of-care
glucometer for the diagnosis of gestational diabetes. Int J Gynaecol
Obstet. 2018;141(1):91-6.
32. van den Berg SA, de Groot MJ, Salden LP, Draad PJ, Dijkstra IM,
Lunshof S, et al. Pregnancy diabetes: A comparison of diagnostic
protocols based on point-of-care, routine and optimized laboratory
conditions. Sci Rep. 2015;5:16302.
33. GALLARDO H, LOMELIN-GASCON J, MARTINEZ LA, MONTOYA A, REYES-MUÑOZ E,
TAPIA-CONYER RC. 1358-P: Point of Care OGTT for the Screening of
Gestational Diabetes: A Feasible Proposal for Low-Resource Settings.
Diabetes. 2020;69(Supplement_1).
34. Kristensen K, Wangel A-M, Katsarou A, Shaat N, Simmons D, Fadl H, et
al. Diagnosis of Gestational Diabetes Mellitus with Point-of-Care
Methods for Glucose versus Hospital Laboratory Method Using Isotope
Dilution Gas Chromatography-Mass Spectrometry as Reference. Journal of
Diabetes Research. 2020;2020:7937403.
35. Landberg E, Nevander S, Hadi M, Blomberg M, Norling A, Ekman B, et
al. Evaluation of venous plasma glucose measured by point-of-care
testing (Accu-Chek Inform II) and a hospital laboratory hexokinase
method (Cobas c701) in oral glucose tolerance testing during pregnancy
– a challenge in diagnostic accuracy. Scandinavian Journal of Clinical
and Laboratory Investigation. 2021;81(8):607-14.
36. SAbo-Elkheir EMM DA, Hazzaa SME, El-Gharib MN. The Accuracy of
Capillary Whole Blood Glucose Versus Venous Plasma Glucose in the
Diagnosis of Gestaonal Diabetes Mellitus in Egypan Women. J Womens
Health Reprod. 2020;Med Vol. 4 No.3:4.
Table 1: Number (n) Percentage % of pregnant women meeting GDM
diagnostic thresholds (fasting ≥ 5.6 mmol/L, 2-hour ≥ 7.8 mmol/L) with
each method, sensitivity and specificity, FP FN rates, PPV and NPV for
POC-StatStrip®.